Samuel Katz, Yale School of Medicine (IMAGE)

Alliance for Cancer Gene Therapy

Samuel Katz, Yale School of Medicine

Caption

The Alliance for Cancer Gene Therapy, the nation's only nonprofit dedicated to cell and gene therapies for cancer, awarded Dr. Samuel Katz of Yale School of Medicine, a grant to study how a patient's T-cells can reprogram and recognize cancer as a threat and then attack only the cancer cells for blood cancers, leaving other cells healthy, with minimal side effects.

Credit

© Yale School of Medicine

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.